Lorundrostat Development Program

At Mineralys Therapeutics, we are focused on developing medicines to target diseases driven by abnormally elevated aldosterone.

Hypertension

CKD

uHTN = uncontrolled hypertension; rHTN = resistant hypertension; CKD = chronic kidney disease

© 2023 Mineralys Therapeutics, Inc.

Terms & Conditions  |  Privacy Policy
Twitter Linkedin